-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Novartis Remibrutinib Delivered Comprehensive Disease Control In Phase III RMS Trials

路透·10/23/2026 16:09:52

請登錄查看新聞詳情